BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Szkwarko D, Hirsch-Moverman Y, Du Plessis L, Du Preez K, Carr C, Mandalakas AM. Child contact management in high tuberculosis burden countries: A mixed-methods systematic review. PLoS One 2017;12:e0182185. [PMID: 28763500 DOI: 10.1371/journal.pone.0182185] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Azit NA, Ismail A, Ahmad N, Ismail R, Ishak S. Factors associated with tuberculosis disease among children who are household contacts of tuberculosis cases in an urban setting in Malaysia. BMC Public Health 2019;19:1432. [PMID: 31675946 DOI: 10.1186/s12889-019-7814-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Barss L, Obeng J, Fregonese F, Oxlade O, Adomako B, Afriyie AO, Frimpong ED, Winters N, Valiquette C, Menzies D. Solutions to improve the latent tuberculosis Cascade of Care in Ghana: a longitudinal impact assessment. BMC Infect Dis 2020;20:352. [PMID: 32423422 DOI: 10.1186/s12879-020-05060-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Lestari T, Graham S, van den Boogard C, Triasih R, Poespoprodjo JR, Ubra RR, Kenangalem E, Mahendradhata Y, Anstey NM, Bailie RS, Ralph AP. Bridging the knowledge-practice gap in tuberculosis contact management in a high-burden setting: a mixed-methods protocol for a multicenter health system strengthening study. Implement Sci 2019;14:31. [PMID: 30890160 DOI: 10.1186/s13012-019-0870-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
4 Campbell JI, Sandora TJ, Haberer JE. A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking. BMJ Glob Health 2021;6:e004836. [PMID: 34016576 DOI: 10.1136/bmjgh-2020-004836] [Reference Citation Analysis]
5 Meremikwu M, Zumla A. Isoniazid preventive therapy for children in sub-Saharan Africa. Lancet Respir Med 2019;7:197-9. [PMID: 30823970 DOI: 10.1016/S2213-2600(19)30037-2] [Reference Citation Analysis]
6 Zellweger J. Is the EU model for contact investigation applicable to high TB burden settings? International Journal of Infectious Diseases 2020;92:S55-9. [DOI: 10.1016/j.ijid.2020.02.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Sekadde MP, Kay AW. Tuberculosis Prevention: an Under Prioritized yet Critical Intervention to Reduce Child Tuberculosis Morbidity and Mortality. Curr Trop Med Rep 2018;5:51-8. [DOI: 10.1007/s40475-018-0139-5] [Reference Citation Analysis]
8 Yuen CM, Millones AK, Puma D, Jimenez J, Galea JT, Calderon R, Pages GS, Brooks MB, Lecca L, Nicholson T, Becerra MC, Keshavjee S. Closing delivery gaps in the treatment of tuberculosis infection: Lessons from implementation research in Peru. PLoS One 2021;16:e0247411. [PMID: 33606824 DOI: 10.1371/journal.pone.0247411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hirsch-Moverman Y, Howard AA, Mantell JE, Lebelo L, Frederix K, Wills A, Hesseling AC, Nachman S, Maama LB, El-Sadr WM. Improving child tuberculosis contact identification and screening in Lesotho: Results from a mixed-methods cluster-randomized implementation science study. PLoS One 2021;16:e0248516. [PMID: 34014956 DOI: 10.1371/journal.pone.0248516] [Reference Citation Analysis]
10 Vonasek B, Ness T, Takwoingi Y, Kay AW, van Wyk SS, Ouellette L, Marais BJ, Steingart KR, Mandalakas AM. Screening tests for active pulmonary tuberculosis in children. Cochrane Database Syst Rev 2021;6:CD013693. [PMID: 34180536 DOI: 10.1002/14651858.CD013693.pub2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Yuen CM, Majidulla A, Jaswal M, Safdar N, Malik AA, Khan AJ, Becerra MC, Keshavjee S, Lu C, Hussain H. Cost of Delivering 12-Dose Isoniazid and Rifapentine Versus 6 Months of Isoniazid for Tuberculosis Infection in a High-Burden Setting. Clin Infect Dis 2021;73:e1135-41. [PMID: 33289039 DOI: 10.1093/cid/ciaa1835] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Otero L, Battaglioli T, Ríos J, De la Torre Z, Trocones N, Ordoñez C, Seas C, Van der Stuyft P. Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data. Trop Med Int Health 2020;25:346-56. [PMID: 31758837 DOI: 10.1111/tmi.13350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
13 Vukugah TA, Ntoh VN, Akoku DA, Leonie S, Jacob A, Asante-poku A. Research Questions and Priorities for Pediatric Tuberculosis: A Survey of Published Systematic Reviews and Meta-Analyses. Tuberculosis Research and Treatment 2022;2022:1-10. [DOI: 10.1155/2022/1686047] [Reference Citation Analysis]
14 Malik AA, Farooq S, Jaswal M, Khan H, Nasir K, Fareed U, Shahbaz S, Amanullah F, Safdar N, Khan AJ, Keshavjee S, Becerra MC, Hussain H. Safety and feasibility of 1 month of daily rifapentine plus isoniazid to prevent tuberculosis in children and adolescents: a prospective cohort study. Lancet Child Adolesc Health 2021;5:350-6. [PMID: 33770510 DOI: 10.1016/S2352-4642(21)00052-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Oxlade O, Benedetti A, Adjobimey M, Alsdurf H, Anagonou S, Cook VJ, Fisher D, Fox GJ, Fregonese F, Hadisoemarto P, Hill PC, Johnston J, Khan FA, Long R, Nguyen NV, Nguyen TA, Obeng J, Ruslami R, Schwartzman K, Trajman A, Valiquette C, Menzies D. Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial. Lancet Public Health 2021;6:e272-82. [PMID: 33765453 DOI: 10.1016/S2468-2667(20)30261-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Chacón A, Alarcón E, López L. [Factors associated with completion of isoniazid preventive therapy in children in Quito, Ecuador (2014-2016 and 2018)Fatores associados à adesão à terapia preventiva com isoniazida em crianças de Quito, Equador (2014-2016 e 2018)]. Rev Panam Salud Publica 2019;43:e97. [PMID: 31892926 DOI: 10.26633/RPSP.2019.97] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Sandoval M, Swamy P, Kay AW, Alonso PU, Dube GS, Hlophe-Dlamini H, Mandalakas AM. Distinct Risk Factors for Clinical and Bacteriologically Confirmed Tuberculosis among Child Household Contacts in a High-Burden Setting. Am J Trop Med Hyg 2020;103:2506-9. [PMID: 32996456 DOI: 10.4269/ajtmh.20-0522] [Reference Citation Analysis]
18 Reuter A, Hughes J, Furin J. Challenges and controversies in childhood tuberculosis. The Lancet 2019;394:967-78. [DOI: 10.1016/s0140-6736(19)32045-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 6.7] [Reference Citation Analysis]
19 Salazar-Austin N, Dowdy DW, Chaisson RE, Golub JE. Seventy Years of Tuberculosis Prevention: Efficacy, Effectiveness, Toxicity, Durability, and Duration. Am J Epidemiol 2019;188:2078-85. [PMID: 31364692 DOI: 10.1093/aje/kwz172] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Zegarra-Chapoñan R, Bonadonna LV, Yuen CM, Martina-Chávez MB, Zeladita-Huaman J. Implementation of isoniazid preventive therapy in southern Lima, Peru: an analysis of health center characteristics. Infect Dis Poverty 2021;10:63. [PMID: 33962691 DOI: 10.1186/s40249-021-00845-0] [Reference Citation Analysis]
21 Hirsch-Moverman Y, Howard AA, Frederix K, Lebelo L, Hesseling A, Nachman S, Mantell JE, Lekhela T, Maama LB, El-Sadr WM. The PREVENT study to evaluate the effectiveness and acceptability of a community-based intervention to prevent childhood tuberculosis in Lesotho: study protocol for a cluster randomized controlled trial. Trials 2017;18:552. [PMID: 29157275 DOI: 10.1186/s13063-017-2184-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
22 Yuen CM, Millones AK, Contreras CC, Lecca L, Becerra MC, Keshavjee S. Tuberculosis household accompaniment to improve the contact management cascade: A prospective cohort study. PLoS One 2019;14:e0217104. [PMID: 31100097 DOI: 10.1371/journal.pone.0217104] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
23 Salazar-Austin N, Milovanovic M, West NS, Tladi M, Barnes GL, Variava E, Martinson N, Chaisson RE, Kerrigan D. Post-trial perceptions of a symptom-based TB screening intervention in South Africa: implementation insights and future directions for TB preventive healthcare services. BMC Nurs 2021;20:29. [PMID: 33557831 DOI: 10.1186/s12912-021-00544-z] [Reference Citation Analysis]
24 Vonasek B, Ness T, Takwoingi Y, Kay AW, van Wyk SS, Ouellette L, Marais BJ, Steingart KR, Mandalakas AM; Cochrane Infectious Diseases Group. Screening tests for active pulmonary tuberculosis in children. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd013693] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Kay AW, Ness TE, Martinez L, Mandalakas AM. It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV. Am J Trop Med Hyg 2020;103:1348-9. [PMID: 32876009 DOI: 10.4269/ajtmh.20-1089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Padmapriyadarsini C, Sachdeva KS, Nair D, Ramachandran R. The paradigm shift in the approach to management of latent tuberculosis infection in high tuberculosis burden countries. Expert Rev Respir Med 2021;15:899-910. [PMID: 33302729 DOI: 10.1080/17476348.2021.1862652] [Reference Citation Analysis]
27 Fry S, Barnabas S, Cotton MF. Update on trends in childhood tuberculosis. Curr Opin Pediatr 2018;30:152-60. [PMID: 29194073 DOI: 10.1097/MOP.0000000000000581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Yuen CM, Millones AK, Galea JT, Puma D, Jimenez J, Lecca L, Becerra MC, Keshavjee S. Toward patient-centered tuberculosis preventive treatment: preferences for regimens and formulations in Lima, Peru. BMC Public Health 2021;21:121. [PMID: 33430823 DOI: 10.1186/s12889-020-10098-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Huynh J, Abo YN, du Preez K, Solomons R, Dooley KE, Seddon JA. Tuberculous Meningitis in Children: Reducing the Burden of Death and Disability. Pathogens 2021;11:38. [PMID: 35055986 DOI: 10.3390/pathogens11010038] [Reference Citation Analysis]
30 Ochi H, Taira K, Nemoto N, Oikawa N, Nagao S, Takano T, Kaneko K. Endoscopic Surgery under Fluoroscopic Guidance Is Useful for Diagnosing and Treating Epiphyseal Osteomyelitis Caused by Mycobacterium Species. Case Rep Orthop 2018;2018:8136150. [PMID: 30009067 DOI: 10.1155/2018/8136150] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Hirsch-Moverman Y, Strauss M, George G, Mutiti A, Mafukidze A, Shongwe S, Dube GS, El Sadr WM, Mantell JE, Howard AA. Paediatric tuberculosis preventive treatment preferences among HIV-positive children, caregivers and healthcare providers in Eswatini: a discrete choice experiment. BMJ Open 2021;11:e048443. [PMID: 34686549 DOI: 10.1136/bmjopen-2020-048443] [Reference Citation Analysis]
32 Emerson C, Ng'eno B, Ngowi B, Pals S, Kohi W, Godwin M, Date A, Modi S. Assessment of routine screening of pediatric contacts of adults with tuberculosis disease in Tanzania. Public Health Action 2019;9:148-52. [PMID: 32042606 DOI: 10.5588/pha.19.0034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Hirsch-Moverman Y, Mantell JE, Lebelo L, Howard AA, Hesseling AC, Nachman S, Frederix K, Maama LB, El-Sadr WM. Provider attitudes about childhood tuberculosis prevention in Lesotho: a qualitative study. BMC Health Serv Res 2020;20:461. [PMID: 32450858 DOI: 10.1186/s12913-020-05324-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Osman M, Karat AS, Khan M, Meehan SA, von Delft A, Brey Z, Charalambous S, Hesseling AC, Naidoo P, Loveday M. Health system determinants of tuberculosis mortality in South Africa: a causal loop model. BMC Health Serv Res 2021;21:388. [PMID: 33902565 DOI: 10.1186/s12913-021-06398-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 Lee G, Meyer AJ, Kizito S, Katamba A, Davis JL, Armstrong-Hough M. Predictors of evaluation in child contacts of TB patients. Int J Tuberc Lung Dis 2020;24:847-9. [PMID: 32912391 DOI: 10.5588/ijtld.20.0108] [Reference Citation Analysis]
36 Amisi JA, Carter EJ, Masini E, Szkwarko D. Closing the loop in child TB contact management: completion of TB preventive therapy outcomes in western Kenya. BMJ Open 2021;11:e040993. [PMID: 33622944 DOI: 10.1136/bmjopen-2020-040993] [Reference Citation Analysis]
37 Szkwarko D, Owiti P, Buziba N, Bigelow C, Eaton CB, Carter EJ. Implementation of an active, clinic-based child tuberculosis contact management strategy in western Kenya. Public Health Action 2018;8:91-4. [PMID: 29946526 DOI: 10.5588/pha.17.0119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
38 Wobudeya E, Jaganath D, Sekadde MP, Nsangi B, Haq H, Cattamanchi A. Outcomes of empiric treatment for pediatric tuberculosis, Kampala, Uganda, 2010-2015. BMC Public Health 2019;19:446. [PMID: 31035984 DOI: 10.1186/s12889-019-6821-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
39 Ndakidemi E, Emerson C, Medley A, Ngowi B, Ng'eno B, Munuo G, Kohi W, Modi S. Health care worker perspectives on TB case finding and HIV services among pediatric TB patients in Tanzania. Int J Tuberc Lung Dis 2019;23:811-6. [PMID: 31439112 DOI: 10.5588/ijtld.18.0445] [Reference Citation Analysis]
40 Hirsch-Moverman Y, Mantell JE, Lebelo L, Wynn C, Hesseling AC, Howard AA, Nachman S, Frederix K, Maama LB, El-Sadr WM. Tuberculosis preventive treatment preferences among care givers of children in Lesotho: a pilot study. Int J Tuberc Lung Dis 2018;22:858-62. [PMID: 29991393 DOI: 10.5588/ijtld.17.0809] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 Seddon JA, Whittaker E, Kampmann B, Lewinsohn DA, Osman M, Hesseling AC, Rustomjee R, Amanullah F. The evolving research agenda for paediatric tuberculosis infection. Lancet Infect Dis 2019;19:e322-9. [PMID: 31221543 DOI: 10.1016/S1473-3099(18)30787-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
42 Salazar-Austin N, Cohn S, Barnes GL, Tladi M, Motlhaoleng K, Swanepoel C, Motala Z, Variava E, Martinson N, Chaisson RE. Improving Tuberculosis Preventive Therapy Uptake: A Cluster-randomized Trial of Symptom-based Versus Tuberculin Skin Test-based Screening of Household Tuberculosis Contacts Less Than 5 Years of Age. Clin Infect Dis 2020;70:1725-32. [PMID: 31127284 DOI: 10.1093/cid/ciz436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Malik AA, Fuad J, Siddiqui S, Amanullah F, Jaswal M, Barry Z, Jabeen F, Fatima R, Yuen CM, Salahuddin N, Khan AJ, Keshavjee S, Becerra MC, Hussain H. Tuberculosis Preventive Therapy for Individuals Exposed to Drug-resistant Tuberculosis: Feasibility and Safety of a Community-based Delivery of Fluoroquinolone-containing Preventive Regimen. Clin Infect Dis 2020;70:1958-65. [PMID: 31190072 DOI: 10.1093/cid/ciz502] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
44 Vasiliu A, Salazar-Austin N, Trajman A, Lestari T, Mtetwa G, Bonnet M, Casenghi M. Child Contact Case Management-A Major Policy-Practice Gap in High-Burden Countries. Pathogens 2021;11:1. [PMID: 35055949 DOI: 10.3390/pathogens11010001] [Reference Citation Analysis]
45 Furin J. Advances in the diagnosis, treatment, and prevention of tuberculosis in children. Expert Rev Respir Med 2019;13:301-11. [PMID: 30648437 DOI: 10.1080/17476348.2019.1569518] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
46 Reuter A, Seddon JA, Marais BJ, Furin J. Preventing tuberculosis in children: A global health emergency. Paediatr Respir Rev 2020;36:44-51. [PMID: 32253128 DOI: 10.1016/j.prrv.2020.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
47 Dodd PJ, Yuen CM, Becerra MC, Revill P, Jenkins HE, Seddon JA. Potential effect of household contact management on childhood tuberculosis: a mathematical modelling study. Lancet Glob Health 2018;6:e1329-38. [PMID: 30266570 DOI: 10.1016/S2214-109X(18)30401-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 8.3] [Reference Citation Analysis]
48 Szkwarko D, Hirsch-Moverman Y. One size does not fit all: preventing tuberculosis among child contacts. BMJ Glob Health 2019;4:e001950. [PMID: 31908872 DOI: 10.1136/bmjgh-2019-001950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
49 du Preez K, Jenkins HE, Donald PR, Solomons RS, Graham SM, Schaaf HS, Starke JR, Hesseling AC, Seddon JA. Tuberculous Meningitis in Children: A Forgotten Public Health Emergency. Front Neurol 2022;13:751133. [DOI: 10.3389/fneur.2022.751133] [Reference Citation Analysis]
50 Zeladita-Huaman J, Yuen CM, Zegarra-Chapoñan R, Curisinche-Rojas M, Egusquiza-Pozo V. Caregivers' knowledge and perceptions are associated with children's TB preventive treatment completion. Public Health Action 2021;11:85-90. [PMID: 34159068 DOI: 10.5588/pha.21.0009] [Reference Citation Analysis]
51 Barss L, Menzies D. Using a quality improvement approach to improve care for latent tuberculosis infection. Expert Rev Anti Infect Ther 2018;16:737-47. [PMID: 30318977 DOI: 10.1080/14787210.2018.1521269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
52 Amanullah F, Bacha JM, Fernandez LG, Mandalakas AM. Quality matters: Redefining child TB care with an emphasis on quality. J Clin Tuberc Other Mycobact Dis 2019;17:100130. [PMID: 31788571 DOI: 10.1016/j.jctube.2019.100130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Vasiliu A, Eymard-Duvernay S, Tchounga B, Atwine D, de Carvalho E, Ouedraogo S, Kakinda M, Tchendjou P, Turyahabwe S, Kuate AK, Tiendrebeogo G, Dodd PJ, Graham SM, Cohn J, Casenghi M, Bonnet M. Community intervention for child tuberculosis active contact investigation and management: study protocol for a parallel cluster randomized controlled trial. Trials 2021;22:180. [PMID: 33653385 DOI: 10.1186/s13063-021-05124-9] [Reference Citation Analysis]